Skip to main content
Caplight Logo









Novalogy, Inc.

Novalogy, Inc.

Private
Claymont, DelawareConsumer & Commercehttps://goayo.com/

Last Round

Seed

Oct 31, 2016

Total Funding Raised

$440,000

Company Overview

Novalogy, Inc. is a health and wellness technology company that develops AYO, a wearable light therapy device and mobile application designed to regulate circadian rhythms and improve sleep, energy, and overall well-being.

Sector

Consumer & Commerce

Verticals

Consumer Electronics, D2C Brands, Health IoT, Medical Devices

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

light therapy glassescircadian rhythmwearable technologyjet lag reliefsleep improvementblue light therapybiohackingsleep techcircadian healthhealth IoTD2C hardwarewellness wearableshift work aidlight therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novalogy, Inc. Comparables

Compare Novalogy, Inc. with similar companies based on industry and business-model similarity.

Novalogy, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lumos Health
93%
Luminette
91%
Re-Time Pty Ltd
91%

Novalogy, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 31, 2016
GrantMar 11, 2016
CrowdfundingMay 19, 2015

Key People

Founding team and executive leadership

Alexander Dimitrov

Co-Founder & Chief Commercial Officer

Founding Team

Branislav Nikolic

CEO & Co-founder

Founding Team

Milan Scepanovic

Chief Financial Officer

Executive Team

Novalogy, Inc. Investors

Notable investors and investment history

Novalogy, Inc. investors
InvestorRounds
Parallel18Grant
Eleven VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 36% MoM to 60.6K.

  • Oct 29, 2024

    Monthly visitors grew 74% MoM, reaching 13.6K.

Novalogy, Inc. Filings

Explore SEC and related filing metadata, where available.

Novalogy, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novalogy, Inc.'s valuation, stock price, and market status.

Is Novalogy, Inc. a public or private company?

Novalogy, Inc. is a private company.

What is the current stock price of Novalogy, Inc.?

Novalogy, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Novalogy, Inc. worth (valuation)?

Valuation information for Novalogy, Inc. is not publicly available.

Can I buy Novalogy, Inc. stock?

Novalogy, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novalogy, Inc.'s last funding round?

Novalogy, Inc.'s most recent funding round was Seed on October 31, 2016.

Who are the main investors in Novalogy, Inc.?

Key investors in Novalogy, Inc. include Parallel18, Eleven.

Will Novalogy, Inc. IPO soon?

No public IPO plans have been announced for Novalogy, Inc..

How can I track Novalogy, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novalogy, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersClaymont, Delaware
Employee Range4
Year Founded2015
Last FundingOct 31, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?